Allarity Therapeutics
NASDAQ: ALLRCambridge, US · Founded 2021 · Delaware corporation
Allarity Therapeutics is a clinical-stage precision medicine company that uses its proprietary Drug Response Predictor technology to match cancer patients with therapies tailored to their disease. The company develops oncology drugs for difficult-to-treat cancers and is focused on improving patient outcomes through personalized treatment approaches.
Founders & leadership
Allarity Therapeutics was founded in 2021 by Steen Knudsen.
Reported raises · per SEC filings
Form D private placements$26.9M disclosed across 6 rounds · 2021–2024
▶$400KraisedFeb 2024 · 1 investors · BiotechnologyRule 506(b)
▶$400KraisedFeb 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas JensenExecutive Officer, Director
- Gerald McLaughlinDirector
- Laura BenjaminDirector
- Joan BrownExecutive Officer
- Joseph VazzanoDirector
- Offering amount
- $1.4M
- Amount sold
- $400K
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1.6MraisedSep 2023 · 2 investors · BiotechnologyRule 506(b)
▶$1.6MraisedSep 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gerald McLaughlinDirector
- James CullemExecutive Officer, Director
- Joseph VazzanoDirector
- Laura BenjaminDirector
- Joan BrownExecutive Officer
- Thomas JensenDirector
- Amount sold
- $1.6M
- Sales commissions
- $170.7K
- Placement agents
- A.G.P./Alliance Global Partners
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3.4MraisedApr 2023 · 1 investors · BiotechnologyRule 506(b)
▶$3.4MraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James G. CullemExecutive Officer, Director
- Gerald McLaughlinDirector
- Steen KnudsenExecutive Officer
- Marie FoeghExecutive Officer
- David A. RothDirector
- Thomas JensenExecutive Officer, Director
- Joan BrownExecutive Officer
- Amount sold
- $3.4M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$350KraisedApr 2023 · 1 investors · BiotechnologyRule 506(b)
▶$350KraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gerald McLaughlinDirector
- Steen KnudsenExecutive Officer
- Thomas JensenExecutive Officer, Director
- David A. RothDirector
- Marie FoeghExecutive Officer
- Joan BrownExecutive Officer
- James G. CullemExecutive Officer, Director
- Offering amount
- $350K
- Amount sold
- $350K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1.2MraisedMar 2023 · 1 investors · BiotechnologyRule 506(b)
▶$1.2MraisedMar 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James G. CullemExecutive Officer, Director
- Gerald McLaughlinDirector
- Thomas JensenDirector
- Joan BrownExecutive Officer
- David A. RothDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$20MraisedMay 2021 · 1 investors · BiotechnologyRule 506(b)
▶$20MraisedMay 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James G. CullemExecutive Officer
- Steve CarchediExecutive Officer, Director
- Jens Erik KnudsenExecutive Officer
- Offering amount
- $40M
- Amount sold
- $20M
- Sales commissions
- $1.5M
- Placement agents
- LifeSci Capital LLC
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Robinhood9 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Public8 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
TradingView8 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
TipRanks7 shared keywordsFinancial analysis and stock research platform.
Vested Finance6 shared keywordsVested Finance is an investment platform that lets Indian residents and NRIs invest in over 10,000 US stocks and ETFs, including full and fractional shares. Securities are offered through VF Securities Inc. with brokerage execution handled by partner DriveWealth.
Companies competing with Allarity Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Allarity Therapeutics do?
- Allarity Therapeutics is a clinical-stage precision medicine company that uses its proprietary Drug Response Predictor technology to match cancer patients with therapies tailored to their disease. The company develops oncology drugs for difficult-to-treat cancers and is focused on improving patient outcomes through personalized treatment approaches.
- Who founded Allarity Therapeutics?
- Allarity Therapeutics was founded by Steen Knudsen in 2021.
- How much funding has Allarity Therapeutics raised?
- Allarity Therapeutics has disclosed $26.9M raised across 6 rounds.
- Where is Allarity Therapeutics headquartered?
- Allarity Therapeutics is headquartered in Cambridge, US.